Cite
Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics.
MLA
Zhang, Xudong, et al. “Nomograms for Predicting Recurrence of HER2‐positive Breast Cancer with Different HR Status Based on Ultrasound and Clinicopathological Characteristics.” Cancer Medicine, vol. 13, no. 17, Sept. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1002/cam4.70146.
APA
Zhang, X., Kong, H., Liu, X., Li, Q., Fang, X., Wang, J., Qin, Z., Hu, N., Tian, J., Cui, H., & Zhang, L. (2024). Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics. Cancer Medicine, 13(17), 1–14. https://doi.org/10.1002/cam4.70146
Chicago
Zhang, Xudong, Hanqing Kong, Xiaoxue Liu, Qingxiang Li, Xinran Fang, Junjia Wang, Zihao Qin, et al. 2024. “Nomograms for Predicting Recurrence of HER2‐positive Breast Cancer with Different HR Status Based on Ultrasound and Clinicopathological Characteristics.” Cancer Medicine 13 (17): 1–14. doi:10.1002/cam4.70146.